<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saha A</submitter><funding>NCI NIH HHS</funding><pagination>e1002573</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3305458</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(3)</volume><pubmed_abstract>EBV latent antigen EBNA3C is indispensible for in vitro B-cell immortalization resulting in continuously proliferating lymphoblastoid cell lines (LCLs). EBNA3C was previously shown to target pRb for ubiquitin-proteasome mediated degradation, which facilitates G1 to S transition controlled by the major transcriptional activator E2F1. E2F1 also plays a pivotal role in regulating DNA damage induced apoptosis through both p53-dependent and -independent pathways. In this study, we demonstrate that in response to DNA damage LCLs knocked down for EBNA3C undergo a drastic induction of apoptosis, as a possible consequence of both p53- and E2F1-mediated activities. Importantly, EBNA3C was previously shown to suppress p53-induced apoptosis. Now, we also show that EBNA3C efficiently blocks E2F1-mediat</pubmed_abstract><journal>PLoS pathogens</journal><pubmed_title>E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.</pubmed_title><pmcid>PMC3305458</pmcid><funding_grant_id>CA137894-02</funding_grant_id><funding_grant_id>R01 CA138434</funding_grant_id><funding_grant_id>R01 CA137894</funding_grant_id><funding_grant_id>CA138434-02</funding_grant_id><pubmed_authors>Saha A</pubmed_authors><pubmed_authors>Morizur L</pubmed_authors><pubmed_authors>Upadhyay SK</pubmed_authors><pubmed_authors>Lu J</pubmed_authors><pubmed_authors>Robertson ES</pubmed_authors><pubmed_authors>Aj MP</pubmed_authors></additional><is_claimable>false</is_claimable><name>E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.</name><description>EBV latent antigen EBNA3C is indispensible for in vitro B-cell immortalization resulting in continuously proliferating lymphoblastoid cell lines (LCLs). EBNA3C was previously shown to target pRb for ubiquitin-proteasome mediated degradation, which facilitates G1 to S transition controlled by the major transcriptional activator E2F1. E2F1 also plays a pivotal role in regulating DNA damage induced apoptosis through both p53-dependent and -independent pathways. In this study, we demonstrate that in response to DNA damage LCLs knocked down for EBNA3C undergo a drastic induction of apoptosis, as a possible consequence of both p53- and E2F1-mediated activities. Importantly, EBNA3C was previously shown to suppress p53-induced apoptosis. Now, we also show that EBNA3C efficiently blocks E2F1-mediat</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2025-04-22T06:58:31.732Z</modification><creation>2019-03-27T00:51:13Z</creation></dates><accession>S-EPMC3305458</accession><cross_references><pubmed>22438805</pubmed><doi>10.1371/journal.ppat.1002573</doi></cross_references></HashMap>